EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete iD, Carlo Cota

Dermatology Reports · 11.11.2024 · 17 (2)

DOI: 10.4081/dr.2024.10140 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Dermatology Reports, online erschienen am 11.11.2024. Verfasst von Viviana Lora und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, San Gallicano Dermatological Institute, Rome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of psoriasis associated with human immunodeficiency virus (HIV) infection is challenging due to the high incidence of comorbidities and polypharmacy and the lack of evidence on the efficacy and safety of available drugs in these patients. Therefore, clinical or anecdotal reports provide useful indications for therapy decision-making. A 64-year-old male with plaque psoriasis (Psoriasis Area and Severity Index [PASI]=14.3) infected with HIV for 4 years, with hypercholesterolemia, hypertension, and impaired quality of life (Dermatology Life Quality Index [DLQI]=14) was resistant to topical therapy and acitretin. Tildrakizumab 200 mg was started, obtaining a PASI score of 0 at week 16, which was maintained after 13 months of follow-up. No adverse event was reported, and immune cell levels were unchanged. This is the first report on the treatment of psoriasis with tildrakizumab in an HIV+ patient. A literature search showed that prior to this patient, 38 HIV+ subjects had been treated with anti-cytokine agents for psoriasis.

Autor:innen und Institutionen

  • Division of Dermatology, San Gallicano Dermatological Institute, Rome.
  • Dermatopathology Unit, San Gallicano Dermatological Institute, Rome.

ORCID-Profile: Monia Di Prete

Zitieren

APA

Lora, V., Graceffa, D., Di Prete, M., & Cota, C. (2024). Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs. Dermatology Reports, 17(2). https://doi.org/10.4081/dr.2024.10140

Vancouver

Lora V, Graceffa D, Di Prete M, Cota C. Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs. Dermatology Reports. 2024;17(2). doi:10.4081/dr.2024.10140

BibTeX
@article{Lora2024,
  author = {Lora, Viviana and Graceffa, Dario and Di Prete, Monia and Cota, Carlo},
  title = {Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs},
  journal = {Dermatology Reports},
  year = {2024},
  volume = {17},
  number = {2},
  doi = {10.4081/dr.2024.10140}
}
Kostenlos starten →